ropivacaine has been researched along with Benign Neoplasms, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, H; Deng, Z; Jian, Y | 1 |
| Batoz, H; Maurette, P; Pellerin, C; Roux, G; Verdonck, O | 1 |
1 trial(s) available for ropivacaine and Benign Neoplasms, Brain
| Article | Year |
|---|---|
The analgesic properties of scalp infiltrations with ropivacaine after intracranial tumoral resection.
Topics: Adult; Aged; Amides; Analgesia; Anesthesia, Local; Brain Neoplasms; Female; Humans; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Prospective Studies; Ropivacaine; Scalp; Single-Blind Method | 2009 |
1 other study(ies) available for ropivacaine and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Ropivacaine represses the proliferation, invasion, and migration of glioblastoma via modulating the microRNA-21-5p/KAT8 regulatory NSL complex subunit 2 axis.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Histone Acetyltransferases; Humans; MicroRNAs; Ropivacaine | 2022 |